Comunicati Stampa
Scienza e Tecnologia

XNK Therapeutics to present at ABGSC Private Companies Seminar on December 6

For more information, please contact: For more information, please contact: Johan Liwing, CEO, XNK TherapeuticsTel: +46 706 70 36 75 E-mail:johan.liwing@xnktherapeutics.com This information was brought to you by Cisionhttp://news.cision.com https://news.cision.com/xnk-therapeutics-ab/r/xnk-therapeutics-to-present-at-abgsc-private-companies-seminar-on-december-6,c3463308 The following files are available for download:
STOCKHOLM, (informazione.news - comunicati stampa - scienza e tecnologia)

Johan Liwing, CEO, XNK Therapeutics
Tel: +46 706 70 36 75
E-mail: johan.liwing@xnktherapeutics.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/xnk-therapeutics-ab/r/xnk-therapeutics-to-present-at-abgsc-private-companies-seminar-on-december-6,c3463308

The following files are available for download:

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Non disponibili